Biopreservation Media is being increasingly used by the life sciences companies to develop tissue or cell-related therapies. Many academic institutions, governments, healthcare establishments, pharmaceuticals and bio technology companies are funding biorepositories and bio banks clinical research. Increasing healthcare expenditure and rise in demand for novel bio-preservatives techniques is expected to aid the growth of the market.
Global Biopreservation Market is valued at USD 3456 Million in 2019 and is estimated to reach USD 6386 Million by 2024 with a CAGR of 13.07% from the forecast year 2019 to 2024. With the growing prevalence of chronic diseases like cancer, cardiovascular diseases, diabetes and acute respiratory diseases, Biopreservation is gaining significance.
Biopreservation is a process of storing the biological samples in an environment suitable for their survival. Biological samples that can be stored with the help of biopreservation typically include plasma, saliva, cells, tissues, body fluids, and organs. Biobanks are increasingly adopting automated systems and software tools to improve storage, management, and retrieval of HBS without sacrificing sample sustainability and integrity. Given the growing volume and diversity of Human Biological Samples that need to be preserved, efficient utilization of storage space down to each refrigerator or a freezer unit is critical. With the emergence of Micro-Electromechanical Systems (MEMS) and Radio Frequency Identification Systems (RFIS) as a cost-effective and error-free technologies for labeling biosamples, biobanks have able to serve several long-term benefits compared to the traditional methods.
The drivers of the biopreservation market include increasing healthcare expenditure, increased demand for preserving newborn's cord cells, increasing R&D spending on research advances in the regenerative market, drug discovery and biobanks, investments by government and non-government corporate organizations.
Advancements in the field of personalized and diagnostics medicines, increasing biopreservation applications and new facilities are also expected to act as a growth catalyst for the market. However, the market growth is hampered by a few restraints that include high cost related to technologically advanced products and stability issues of specimens.
The global biopreservation market is segmented based on the product type as biopreservation media, biopreservation equipment, and lab information system management. Based on the bio-specimens, the market is categorized as human tissue samples, organs, stem cells and other bio-specimens. Based on application, biopreservation market is analyzed as therapeutic applications, research applications, clinical trials and other applications. Based on the end-users, the market is segmented as biobanks, gene banks, hospitals and others.
The global market is segmented based on the geographical region as
The major players in the biopreservation market include BioLife Solutions, Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Corporation, BioCision LLC, VWR Corporation, Cesca Therapeutics Inc., Taylor-Wharton, So-Low Environmental Equipment Co., Panasonic Corporation and Lifeline Scientific Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Biopreservation Media
5.1.2 Biopreservation equipment
5.1.3 Lab Information System Management
5.2 By Bio-Specimens
5.2.1 Human tissue samples
5.2.2 Organs
5.2.3 Stem cells
5.2.4 Other bio-specimens
5.3 By Application
5.3.1 Therapeutic applications
5.3.2 Research applications
5.3.3 Clinical trials
5.3.4 Other applications
5.4 By End-User
5.4.1 Biobanks
5.4.2 Gene Banks
5.4.3 Hospitals
5.4.4 Others
6. Geographical Analysis
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1BioLife Solutions
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Sigma-Aldrich Corporation
8.4 BioCision LLC
8.5 VWR Corporation
8.6 Cesca Therapeutics
8.7 Taylor-Wharton
8.8 So-Low Environmental Equipment
8.9 Panasonic Corporation
8.10 Lifeline Scientific
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
